©The Author(s) 2025.
World J Clin Oncol. Jun 24, 2025; 16(6): 107255
Published online Jun 24, 2025. doi: 10.5306/wjco.v16.i6.107255
Published online Jun 24, 2025. doi: 10.5306/wjco.v16.i6.107255
Table 4 Outcomes of salvage surgery, n (%)
| Treatment outcome | Patients (n = 28) |
| Follow-up time, median (range), months | 14.6 (1.3-42.1) |
| Number of relapsed patients | 13 (46.4) |
| Recurrence | |
| Intrahepatic | 7 (25.0) |
| Extrahepatic | 2 (7.1) |
| Intrahepatic combined with extrahepatic | 4 (14.3) |
| Therapeutic measures after relapse | |
| Microwave | 1 (3.6) |
| Systemic therapy + targeted therapy | 7 (25.0) |
| Systemic therapy + targeted therapy + TACE | 2 (7.1) |
- Citation: Zhang SB, Nashan B, Wang YL, Zhang SG. Efficacy of salvage surgery for hepatocellular carcinoma following conversion therapy. World J Clin Oncol 2025; 16(6): 107255
- URL: https://www.wjgnet.com/2218-4333/full/v16/i6/107255.htm
- DOI: https://dx.doi.org/10.5306/wjco.v16.i6.107255